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A B S T R A C T   
The use of composite materials, processed as 3D tissue-like scaffolds, has been widely investigated as a promising 
strategy for bone tissue engineering applications. Also, additive manufacturing technologies such as fused 
deposition modelling (FDM) have greatly contributed to the manufacture of patient-specific scaffolds with 
predefined pore structures and intricate geometries. However, conventional FDM techniques require the use of 
materials exclusively in the form of filaments, which in order to produce composite scaffolds lead to additional 
costs for the fabrication of precursor filaments as well as multi-step production methods. In this study, we 
propose the use of an advantageous extrusion-based printing technology, which provides the opportunity to 
easily co-print biomaterials, starting from their raw forms, and by using a single-step manufacturing and solvent- 
free process. Poly(e-caprolactone) (PCL), an FDA approved biodegradable material, was used as polymeric matrix 
while hydroxyapatite (HA) and strontium substituted HA (SrHA), at various contents were introduced as a 
bioactive reinforcing phase capable of mimicking the mineral phase of natural bone. Three different architectures 
for each material formulation were designed, and subsequently the effect of composition variations and struc-
tural designs was analysed in terms of physico-chemical, mechanical and biological performance. A correlation 
between architecture and compressive modulus, regardless the formulation tested, was observed demonstrating 
how the laydown pattern influences the resulting 3D printed scaffolds’ stiffness. Furthermore, in vitro cell culture 
by using TERT Human Mesenchymal Stromal Cells (hTERT-MSCs) revealed that Sr-containing composite scaf-
folds showed greater levels of mineralisation and osteogenic potential in comparison to bare PCL and pure HA.   
1. Introduction 
Natural bone is a complex and hierarchically structured composite 
material based on a specifically mineralized extracellular matrix (ECM) 
and cells. The ECM consists of 35% organic matrix, mostly collagen, and 
65% minerals, mostly of HA crystals, which are found between and 
within the length of collagen fibers. Moreover, it is possible to find other 
minerals and microelements, such as carbonates, Sr, Mg etc. [1]. 
Currently, there is no biomaterial of inorganic or organic nature, which 
can alone meet the requirements of a scaffold suitable for bone tissue 
engineering, thus composites are a promising class of engineered 
biomaterials for bone tissue regeneration. Recently, the combination of 
synthetic polymers and HA particles and their processing through ad-
ditive manufacturing technologies have emerged as a promising strategy 
for the production of 3D bone substitutes [2–4]. Annually, around two 
million bone graft procedures are performed worldwide in order to 
repair bone defects stemming from a disease or a traumatic event [5–7]. 
Bone tissue defects caused by fractures, trauma, disease, and congenital 
disorders represent an important burden for health care systems 
worldwide [7,8]. Over the last twenty years, a wide range of bio-
materials, including bioactive ceramics, metallic biomaterials, bio-
polymers or biocomposites [6,9], along with several conventional (e.g. 
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foam replication and electrospinning) and most recent additive 
manufacturing (AM) technologies have been explored to fabricate 3D 
scaffolds intended for bone tissue repair and regeneration [10–13]. AM 
techniques offer the promising opportunity to fabricate 3D implants 
with differences in spatial distribution of porosities and pore sizes 
starting from a Computer Aided design (CAD) model, and hence 
enabling the possibility to tailor the device geometry according to the 
patient needs [14,15]. Biopolymers currently used for the production of 
3D printed (3DP) bone scaffolds include PCL, poly(lactic acid) (PLA) and 
poly(D,L-lactic-co-glycolic acid) (PLGA) [16–18]. These materials have 
been widely investigated for their biocompatibility, biodegradation 
profile and easy processability [19,20]. Moreover, bioactive ceramics, 
such as bioactive glasses, β-tricalcium phosphate (β-TCP) [21,22] and 
HA [23] have also been widely studied in the Bone Tissue Engineering 
(BTE) field due to their bioactivity in order to promote osteoinduction as 
well osteoconduction, and ultimately due to their similarity to the 
mineral phase of native bone tissue [24]. In addition to this, several 
research works have proved how the incorporation of trace elements 
(such as Zn, Mg, Sr) into bioactive ceramic formulations, and therefore 
their presence into 3D scaffolds, can enhance specific biological re-
sponses [25–29]. Particularly, the beneficial effects of Sr substitution 
into HA are broadly reported [2,30]. The presence of Sr2þ ions has been 
found to increase osteoid formation and regulates calcium metabolism, 
stimulates bone formation and enhances collagen synthesis, both in vitro 
and in vivo [2,31,32]. Also, it promotes osteoblast cell proliferation and 
enhance Alkaline Phosphatase (ALP) activity [30,33,34]. However, 3D 
printed bone scaffolds made from single biomaterials have some limi-
tations, including but not limited to poor bioactivity, wear resistance 
and mechanical performance. In essence, they often lack in the ability of 
matching the anisotropic functional properties of the different human 
bone regions [35,36]. The development of composite structures, based 
on the combination of polymers and bioactive ceramics, and where the 
single phase complements each other’s strengths and weaknesses, has 
contributed to solve the shortcomings deriving from the application of a 
unique biomaterial. However, to create composite scaffolds, the incor-
poration of a ceramic phase within a polymeric matrix has often 
involved the use of organic solvents (i.e. tetrahydrofuran [3] and chlo-
roform [37]) that carry potential cytotoxic effects to the cells. In order to 
overcome this hurdle, most of the current strategies rely on the use of 
FDM 3D printing technologies, where composite scaffolds are produced 
from filaments [4,38,39]. However, in this case raw materials are firstly 
mixed together, subsequently processed in the form of filaments and 
ultimately extruded, leading to a multi-step manufacturing process and 
its inherently additional costs. In this study green chemistry basic 
principles were followed by using an environmentally-friendly product 
development strategy, which have been only marginally investigated in 
the current literature [40–42]. Specifically, a novel solvent-free extru-
sion-based 3D printing approach, which offers the opportunity to easily 
co-print biomaterials from their raw forms, has been investigated in this 
work. Composite scaffolds based on a polymeric matrix of PCL and a 
bioactive reinforcing phase of HA or SrHA (at various contents: 0 wt%, 
10 wt% and 20 wt%) were produced via an advantageous single step and 
solvent-free extrusion-based 3D printing technology (see Fig. 1). Sub-
sequently, we evaluated the effect of scaffolds’ structural design and 
material formulations on mechanical properties and in vitro behaviour, 
in terms of both biomineralisation and osteogenic potential of TERT 
Human Mesenchymal Stromal Cells (hTERT-MSCs). 
2. Materials and methods 
2.1. Synthesis and characterization of HA and SrHA powders 
HA and SrHA powders were synthesized via aqueous precipitation 
method [43] according to the protocol as reported in the supplementary 
file. 2.46 wt% Sr concentration in SrHA powder was targeted based on 
literature review [44,45] and our unpublished results. Before composite 
scaffold manufacturing, the as-synthesized powders were calcined at 
650 �C for 2 h. Subsequently, synthesized powders were characterized 
using the following equipment and methods: X-Ray diffraction (XRD) 
patterns were recorded using system (X’Pert PRO, PANalytical, 
Netherlands) operating at 40 KV and 30 mA using a Cu Kα1 radiation (λ 
¼ 1.5406 Å). The XRD patterns were obtained over the range of 2θ from 
10� to 70� with an angular step interval of 0.0334�. The X’Pert Data 
Viewer and X’Pert HighScore software were used for processing and 
analysing the XRD data. For the phase identification the International 
Centre for Diffraction Data (ICDD) was used (PDF-2/2005 card 
#01-072-1243 for HA). 
Sr content of the powders was determined using atomic absorption 
spectrometry (AAS, Varian SpektrAA 880, Australia). Samples were 
analysed according LVS ISO 11047:1998 standard test method for Sr 
content determination using electrothermal atomization. Bru-
nauer–Emmett–Teller (BET) method was used to determine the specific 
surface area (SSA) of the powders by N2 absorption (QUADRASORB SI 
Kr, Quantachrome, USA). The samples were degassed at room temper-
ature for 24 h prior the analyses. The values of mean sizes of particles 
were estimated from the N2 adsorption isotherms using the BET particle 
diameter (dBET) from the following Eq. (1) by assuming the primary 
particles to be spherical: 
dBET ¼
6
ðq� SSAÞ
(1)  
where q is the theoretical density of apatite, which is equal to 3.156 g/ 
cm3 (according to ISO 13175-3:2012). 
2.2. Preparation and characterisation of composite material formulations 
Powdered PCL with a relative molecular weight of 50 kDa and a 
particle size <600 μm (Polyscience Europe, Germany) and HA, SrHA 
calcined powders were used for this study. Firstly, raw powder materials 
were mechanically mixed together at room temperature. In order to 
avoid the clogging of the needle during the extrusion process and prior 
to mix with the PCL, both HA and SrHA powders were ground and then 
sieved using an analytical sieve with a mesh size of 106 μm. Afterwards, 
PCL, HA, and SrHA powders were mechanically mixed together in 
different proportions, as reported in Table 1. The so obtained composite 
powder mixtures were labelled as PCL/10HA, PCL/10SrHA, PCL/20HA 
and PCL/20SrHA, while pure PCL was used as control. In order to ensure 
a homogenous mixing of the powders, the resulting powder mixtures 
Fig. 1. 3D printed scaffold manufacturing route: A) scaffold CAD models, B) 
precursors’ processing and C) extrusion-based scaffold 3D printing. 
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were kept overnight on a mechanical roller (Stuart Scientific, UK). Prior 
to start the printing process, the ready to be used composite powders 
were stored in a desiccator until usage. The PCL as well as the composite 
powders were analysed with Attenuated Total Reflectance Fourier 
Transform Infrared Spectroscopy (ATR-FTIR). The analyses were carried 
out with a Nicolet iS5 by Thermo Scientific, equipped with an iD5 ATR 
diamond crystal window. All the spectra were measured in the spectral 
range between 500 cm  1 and 4000 cm  1 and a resolution of 4 cm  1. In 
addition to this, the morphology of the precursor materials was inves-
tigated via Scanning Electron Microscopy (SEM, Hitachi FE-SEM 
SU5000) at voltage of 2 kV and working distance of 5.6 mm. Before 
imaging, the samples were firstly gold coated and subsequently fixed on 
aluminium stubs by using carbon tape. The images were collected 
through the equipment’s software. 
2.3. Design and manufacturing of 3D composite scaffolds 
As widely reported in the literature, one of the most critical char-
acteristics of a 3D bone substitute is the capacity to structurally fit to the 
host tissue defect and mimic its inherent biomechanical properties [5,7]. 
In this study composite scaffolds were developed according to three 
different internal architectures. A representation of the inner geometry, 
external shape and the cross-section of the three architectures is re-
ported in Fig. 2. Architecture 1 has been chosen because it represents the 
most widely applied tissue-like structure, and it can be considered as a 
control pattern [3,14,46]. This was produced using a laydown pattern of 
0/90� to create porous structures (e.g. the layer 3 is orthogonal to layer 2 
and is printed in the same relative position of layer 1). The distance 
between the strands was set at 0.8 mm, calculated from the centre of the 
strands. This architecture will be named hereafter as Not Shifted Not 
Graded (NSNG). Architecture 2 has been selected after the review of the 
current literature, where is clearly demonstrated that the offset pattern 
allows an increased pore interconnectivity and a better in vitro 
behaviour [17,47,48]. The shifted pattern was realised using the same 
0/90� pattern with 0.8 mm distance between strands, although in this 
case the layers with the same orientation were produced with an offset 
distance equal to half the distance between strands (0.4 mm). This will 
be called Shifted Not Graded (SNG) architecture. Architecture 3 has 
been developed in order to produce a structure that could mimic the 
gradient architecture of human bone tissue [49–51]. This pattern was 
obtained maintaining the previous described shifted pattern, and adding 
a porosity gradient moving from the bottom to the top of the 3D struc-
ture. The porosity gradient structure was achieved by increasing the 
distance between the strands progressively. Specifically, for the first four 
layers the distance between the strands was set to 0.8 mm; subsequently, 
the distance was increased by 0.1 mm every two layers. This architecture 
will be named hereafter as Shifted Graded (SG) structure. To create 
computer models for printing, cylindrical geometries with 7 mm diam-
eter and 6 mm height were designed in Solid Edge™ 3D software. These 
were then sliced by using BioplotterRP 3.0 Software (EnvisionTEC, 
Gladbeck, Germany), in order to obtain 14 layers overall (420 μm slicing 
thickness). The extrusion-based printing process for the fabrication of 
the composite scaffolds was carried out as described in a previous study 
[52], by using a 3D-Bioplotter system (EnvisionTEC, Gladbeck; Ger-
many). Briefly, about 4 g of material in form of powder was weighted 
and introduced into a stainless-steel cartridge. Subsequently, the car-
tridge was placed into the high-temperature printing head and heated up 
so that the material was allowed to melt. A nozzle with 0.4 mm internal 
diameter was used to extrude all the material formulations. Following 
on an initial optimisation process, final printing conditions (tempera-
ture, pressure, speed, pre- and post-flow) were set for each composition 
by using the operating software VisualMachine 2.8.115 (EnvisionTEC, 
Gladbeck; Germany), and as reported in Table 2. 
Table 1 
Code and composition of the precursor material formulations.  
CODE COMPOSITION (wt%) 
PCL 100% PCL 
PCL/10HA 90% PCL þ 10% HA 
PCL/10SrHA 90% PCL þ 10% SrHA 
PCL/20HA 80% PCL þ 20% HA 
PCL/20SrHA 80% PCL þ 20% SrHA  
Fig. 2. 3D scaffold architectures (1 ¼ NSNG, 2 ¼ SNG and 3 ¼ SG) and corresponding CAD model rendering of the 3D volume and cross section.  
Table 2 
Optimised printing parameters.   
PCL PCL/ 
10HA 
PCL/ 
10SrHA 
PCL/ 
20HA 
PCL/ 
20SrHA 
Temperature 
(�C) 
130 130 130 140 140 
Pressure (bar) 6.00 6.20 6.20 6.40 6.40 
Speed (mm/s) 0.60 0.50 0.60 0.50 0.60 
Pre-flow (s) 0.45 0.80 0.75 0.75 1.00 
Post-flow (s) 0.10 0.10 0.10 0.10 0.10  
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2.4. Physico-chemical and mechanical characterisation of 3D bioplotted 
scaffolds 
Thermogravimetric analysis (TGA) was performed in order to 
examine both the printed materials’ thermal behaviour and to assess the 
actual ceramic content in the polymeric matrix. The equipment used for 
the test was a TGA2 METTLER TOLEDO™ with a resolution of 1 μg, 
weighing accuracy of 0.005% and weighing precision of 0.0025%. The 
dedicated software STARe™ was used as an interface with the device to 
process the obtained information. TGA analysis was performed in air 
and the initial weight of the samples was measured approximately 
around 10 mg for every test. The resulting curves were normalized to the 
initial mass weight for each sample. Three samples for each composition 
were tested in a range of temperature between 25 and 800 �C with a 
heating rate of 10 �C/min. Microcomputed tomography (Micro CT) 
analysis was performed to evaluate the architecture and topology of the 
printed scaffolds. A Bruker Skyscan 1275 (Bruker, Kontich, Belgium), 
with a Hamamatsu L11871 source and 3 MP active pixel CMOS flat panel 
detector was used. The scans were conducted under 40 kV and 230 μA 
for an exposure time of 49 ms and a pixel resolution of 10 μm. Scans 
were reconstructed, resliced and analysed using NRecon, CTvol and 
CTAn software (Bruker, Kontich, Belgium). 
Then, in order to investigate 3D printed scaffolds’ surface 
morphology and to verify strands’ dimension, SEM analysis was per-
formed using the same equipment reported in the paragraph of section 
2.2; a voltage of 5 kV and a working distance of 5 mm were used for all 
the investigated samples, which were firstly gold coated and subse-
quently fixed on aluminium stubs. 
Scaffold porosity ðPÞ was first calculated theoretically through the 
formula reported in Eq. (2) [53]: 
P¼ 1   πd
2
1
4d2d3
x100 (2)  
using the assigned printing parameters as elements for the calculation, 
and where d1 is the plotted strand diameter, d2 is the distance between 
strands and d3 is the thickness of the layer (see Fig. S1). In addition, the 
overall porosity was calculated experimentally through the actual di-
mensions of d1, d2 and d3 measured from the 2D sections obtained from 
the MicroCT analysis. The measurements on the 2D images were carried 
out using ImageJ, and three different samples were analysed for each 
formulation as well as architecture investigated. 
Compression tests were performed using an Instron 5500S testing 
machine, equipped with a 500N load cell. Specimens with a 7 mm 
diameter and 6 mm height were compressed in the longitudinal direc-
tion at a constant crosshead speed of 0.5 mm/min up to a deformation of 
70% or until the safety range of the load cell was reached. The specimens 
were subjected at 2N preload before the starting of the test. Five spec-
imens were tested for each type of 3D printed scaffold. The Young’s 
Modulus was obtained from the slope of the linear region of the stress- 
strain response curve on the early stage of compressive loading. 
2.5. In vitro biological evaluation 
2.5.1. Cell culture and seeding protocol 
Human TERT immortalised bone marrow stromal cell line was kindly 
supplied by Prof P. Genever (York University) at passage 84. Briefly, 
cells were grown at 37 �C, 5% CO2, in Dulbecco’s Modified Eagle Me-
dium (DMEM; Sigma, UK) supplemented with 10% foetal bovine serum 
(FBS; Thermo Fisher, UK) and a 1% Penicilin Streptomycin (P/S; Sigma, 
UK). After the expansion, cells were used between passage 86 and 90. 
Prior to cell seeding, the PCL, PCL/20HA and PCL/20SrHA scaffolds 
with a 7 mm diameter and 2.5 mm height were sterilized with 70% ethyl 
alcohol solution (ETOH; Sigma, UK) for 20 min and treated with Sudan 
Black (SB) to limit auto fluorescence. Each scaffold was covered with 50 
μL of SB solution (0.3% w/v in Ethanol), incubated for 20 min at 37 �C 
and washed properly twice with Dulbecco’s phosphate-buffered saline 
(PBS; Sigma, UK). Then samples were sterilized under a UV lamp for 30 
min and placed in 48-well plate. hTERT MSCs were suspended in DMEM 
and seeded on each sample at a concentration of 1.5 � 105 cells per 
scaffold and incubated at 37 �C, 5% CO2 for 30 min. Then, fresh DMEM 
was added up to 500 μL of volume. 
2.5.2. Cell viability, morphology and proliferation tests 
The cytocompatibility of the samples was assessed with the Live/ 
Dead assay (LIVE/DEAD® Cell Imaging Kit; Life Technologies, UK), 
according to the manufacturer’s instructions. This fluorescence-based 
kit combines calcein AM and ethidium bromide to yield two-colour 
discrimination of the population of live (green) from the dead (red) 
cells. In brief, 4 μM ethidium homodimer-1 and 10 μM calcein were 
dilute in PBS. Each sample was washed twice with PBS before incubation 
with the staining solution for 30 min at 37 �C. Images were collected at 
day 1 and day 3 using a Nikon A1R inverted confocal microscope. The 
immunostaining analysis were performed fixing in pre-warmed 4% w/v 
paraformaldehyde (PFA) the samples for 15 min and cells were conse-
quently permeabilised using 0.1% v/v Tween20® (Sigma, UK) in PBS for 
three washes. The cells cytoskeleton was stained using Phalloidin, pre-
pared using phalloidin-tetramethylrhodamine B isothiocyanate (1:1000 
in 0.1% PBS/Tween20®) for 20 min at room temperature. Then, for 
staining the cells nuclei samples were washed with 0.1% PBS/ 
Tween20® solution and immersed in DAPI solution (Vector Labora-
tories, UK) (1:2500 in 0.1% PBS/Tween20®) for 20 min at RT. At day 7 
images were collected using a Nikon A1R inverted confocal microscope. 
Cells metabolic activity was analysed with the MTT (Thiazolyl Blue 
Tetrazolium Bromide) assay using a standard kit provided by Sigma, UK. 
The MTT solution was prepared following the supplier instructions, 
obtaining a final concentration of 5 mg/mL, in PBS and the stock solu-
tion was mixed with serum-free DMEM without phenol red. Samples 
were incubated for 4 h at room temperature protected from light. Then, 
MTT media was removed and replaced by 400 μL of dimethyl sulfoxide 
(DMSO, Sigma, UK) for each well and the plates agitated for 30 min on a 
Stuart Mini Microtitre Plate Shaker, in order to dissolve the formazan 
crystals, a product of digestion of the MTT by the cell. Then, 200 μl of 
each well solution (in duplicate) was transferred to a clear bottom 96- 
well plate and a Filter-based multi-mode microplate reader (Biotek, 
UK) was used to measure the absorbance at 570 nm. Measurements were 
taken in triplicate after 1, 3, 7, 14 and 21 days. The estimation of the cell 
number was performed based on a standard curve, generated by seeding 
hTERT-MSCs at different densities (0, 5 000, 10 000, 30 000, 50 000, 
100 000 and from there on up to 500 000 with a 50 000 increase). 
2.5.3. Cell osteogenic differentiation 
Alkaline Phosphatase (ALP) activity as an early osteogenic differ-
entiation marker was measured by using the ALP assay kit (Sigma, UK) 
up to 21 days. Samples were washed with PBS after removing the media 
and fixed in 4% PFA. Following this, cells were washed in 0.1% PBS/ 
Tween20® solution and alkalinised with water/0.1M Tris solution 
(Sigma, UK). Then, the alkaline solution was replaced by 1 ml of ALP 
solution, and samples were incubated at room temperature for 30 min 
protected from light. 100 μL of solution was then taken from each well 
and placed in a clear-bottom 96-well plate to quantify the ALP activity. 
The reading was performed with a spectrometer (ELx800; BioTek In-
struments, UK) at 405 nm. The results are showed based on the values 
obtained from a standard curve, created by placing different concen-
trations of 0.1M Tris/ALP into a 96-well plate. 
2.5.4. Calcium detection: Alizarin Red staining 
Samples were fixed in 4% PFA and washed in PBS twice and stained 
with 1 mL of Alizarin Red solution (Sigma) for the detection of Calcium. 
The incubation was performed at room temperature for 15 min. Then, 
samples were washed with deionised water multiple times and dried 
overnight at 60 �C in a 5% CO2 atmosphere. Imaging of the samples was 
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performed on a stereomicroscope equipped with a digital colour camera 
(Leica Microsystems). The experiment was performed at day 0, 14 and 
21. 
2.6. Statistical analysis 
Tests were performed at least in triplicate for each sample. The re-
sults were represented as mean � standard deviation. Differences be-
tween groups were determined using One-way analysis of variance 
(ANOVA) with Turkey’s multiple comparison test using levels of sta-
tistical significance reported in each figure’s caption. 
3. Results and discussion 
3.1. Composite powders preparation and characterisation 
Several studies on Sr-containing biomaterials in various forms indi-
cate that even as small amounts as 0.1% of Sr might be enough to have 
an impact on both bone formation and remodelling [30,33]. In this work 
HA powders containing 2.46 wt% (24.6 mg Sr per g of the powder) of Sr 
was used as filler for composite scaffolds. The quantitative amount of Sr 
in the samples determined by AAS is shown in Table 3. For SrHA sample 
the measurements confirmed presence of Sr in the powder. Even though 
the measured concentration was similar to what was expected, i.e. 
nominal concentrations, the total uptake of ions in the powders was 
affected due to the used synthesis technique, most likely, during the 
washing steps, which aimed to remove impurities and reaction residues. 
XRD patterns (see Fig. 3) of the calcined HA and SrHA powders used 
for preparation of the composite scaffolds were compared with that of 
standard HA powder by ICDD PDF-2/2005 card #01-072-1243. For all 
powders a good agreement between the experimental data and the 
standard hexagonal HA structure was obtained. Hexagonal structure of 
the powders was confirmed by the triplet between 30.5 deg and 33.5 deg 
with a pronounced peak at 31.78 deg (211 plane) overlapping with two 
others at 32.13 deg (112 plane) and 32.91 deg (300 plane). Broad and 
overlapping characteristic XRD peaks indicated that the powders consist 
of nanostructured HA particles with a high surface area [54]. No 
extraneous phases were detected in the examined 2θ range. Thus, the 
detected amounts of Sr were assumed to refer to the ones incorporated in 
the HA structure. The nanocrystalline nature showed by XRD analysis 
was confirmed by the BET data summarized in Table S2. However, BET 
analysis showed no significant differences between SSA values between 
the powders. Thus, it can be concluded that the incorporation of Sr in the 
HA structure in this case has a negligible effect on the particle size and 
morphology, which is also shown in the SEM micrographs (Fig. S2). 
ATR-FTIR analysis was conducted in order to assess the presence of 
functional groups within the precursor powders (see Fig. 4), prepared as 
previously described. PCL spectra showed the characteristic bands of 
this polymer in agreement with the literature [55,56], corresponding to 
the typical CH2 symmetric and asymmetric bands respectively at 2940 
cm  1 and 2860 cm  1, the carbonyl stretch at 1720 cm  1, the C–O group 
peak at 1723 cm  1, the backbone C─O and C─C stretching in the crys-
talline phase 1293 cm  1, as well as the C─O─C band, 1164 cm  1. In 
relation to HA powders (see Fig. 4A), absorbance bands corresponding 
to the characteristic HA PO4
3  groups appear at 560 cm  1 and 600 cm  1 
(O–P–O bending mode v4), 961 cm  1 (P–O stretching vibration mode 
v1), and 1022 cm
  1 and 1088 cm  1 (P–O stretching vibration mode v3) 
cm  1. The band at 631 cm  1 can be assigned to bending vibrations of the 
structural OH group. The O–H stretching of OH groups is observed at 
3571 cm  1 [57]. As reported in Fig. 4B, no significant differences were 
observed in the SrHA spectra in comparison to the one referring to the 
pure HA (Fig. 4A) [43]. Regarding the mechanically mixed composite 
powders, the ATR-FTIR results (Fig. 4A, B) showed that PCL and ceramic 
phases were both present. Specifically, all the as prepared composite 
powders (PCL/10HA, PCL/20HA, PCL/10SrHA and PCL/20SrHA) 
showed the C–O group peak at 1723 cm  1, the PO43  group at 560/600 
cm  1 and 961/1022/1088 cm  1 along with the CH2 symmetric and 
asymmetric bands. 
3.2. Composite scaffolds: manufacturing, physico-chemical and 
mechanical characterisation 
3D scaffolds were printed according to the conditions listed in 
Table 2, after an initial optimisation process of the following parame-
ters: printing temperature, pressure, speed, pre-flow and post-flow. No 
substantial differences were recorded in terms of printing parameters 
between PCL/10HA and PCL/10SrHA, which might be dictated to the 
similar precursors’ morphology, and in comparison to the pure PCL 
scaffolds; whereas increasing the content of HA phase above 10 wt% 
required higher printing temperature as well as pressure for the pro-
cessing of mechanically mixed composite powders. Also, the content of 
the inorganic component in the extruded materials was analysed by 
TGA, and the results are reported in Fig. S3 as average of three samples. 
As shown, at the temperature of 600 �C, there is no residual substance 
for pure PCL, indicating this material was completely thermal- 
decomposed at that temperature. Regarding the composite formula-
tions, the residue of inorganic material for PCL/10HA, PCL/10SrHA, 
PCL/20HA and PCL/20SrHA were 10.12 � 0.9 wt%, 11.55 � 1.2 wt% 
20.80 � 2.5 wt% and 17.90 � 2.9 wt% respectively, which are consistent 
with the wt% of inorganic component of the as prepared blends. Also, 
similarly to the recent findings reported by Huang et al. [58], it was 
observed that the addition of the nano-ceramic particles slightly reduced 
the degradation temperature of the printed composite scaffolds. How-
ever, since the printing temperature used in our study was below 150 �C, 
it can be concluded that the manufacturing process did not cause any 
material loss. 
Next, the topology as well as the architecture of the 3D printed 
composite scaffolds were investigated through a non-destructive tech-
nique. In Fig. 5 microCT reconstructions for all the printed samples are 
reported. MicroCT investigations indicated the actual presence of the 
ceramic particles homogenously distributed within the PCL matrix, both 
Table 3 
Chemical composition of calcined (650 �C, 2 h) HA and SrHA powders.  
Sample 
designation 
Chemical formula Nominal Sr 
concentration (wt 
%) 
Measured Sr 
concentration (wt 
%) 
HA Ca10(PO4)6(OH)2 – – 
SrHA Ca9.52Sr0.48(PO4)6(OH)2 2.46 3.10 � 0.30  
Fig. 3. XRD patterns of calcined (650 �C, 2 h) HA and SrHA powders.  
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on the surface and in the inner part, as it is possible to visualise from the 
3D reconstructions of the cross sections. In addition, the morphology of 
the 3D printed samples was observed by SEM. As shown in Fig. S4, all 
the scaffolds possessed well-defined strands’ structure. Moreover, the 
pure PCL scaffold as well as the composites with the lower ceramic 
content revealed a smooth surface (Fig. S4 (B, D, F)) while the PCL/ 
20HA and PCL/20SrHA (Fig. S4 (H, J)) presented a large number of 
white spots. According to both microCT reconstructions as well as SEM 
micrographs, all the printed scaffolds displayed a high level of fidelity to 
the original CAD model, further proving the potential of extrusion 
printing process for the production of custom made devices, as exten-
sively demonstrated in recent years [13,38,40]. The measured total 
porosity values for the fabricated composite scaffolds are reported in 
Table 4. According to the data, it is worth noting that theoretical 
porosity values calculated through the formula reported in Eq. (1) are 
consistent with the experimental data derived from microCT scans, thus 
demonstrating the reliability of the approach used. Furthermore, from 
the analysis of the data displayed in the table, for all the investigated 
composite scaffolds the total porosity values were found to be in the 
range of human trabecular bone porosity (30%–90%) [59], with the 
NSNG and SNG architectures showing similar results (~40%). 
The compressive mechanical properties of pure PCL and composite 
scaffolds based on PCL/HA and PCL/SrHA fabricated by extrusion 3D- 
printing were investigated as function of the different architectures. 
Overall the produced composite scaffolds exhibited mechanical prop-
erties in a range of values consistent with recent research studies, in 
which melt extrusion 3D printing systems were used [42,46,60]. 
Moreover, the mechanical performances of all the specimens were found 
to be about one order of magnitude higher with respect to 3D printed 
composite scaffolds manufactured through a solvent-based extrusion 
system [61]. Representative compressive stress–strain curves for the 
NSNG, SNG and SG 3D printed scaffolds are shown in Fig. 6 (A, B, C), 
these results are consistent with the findings reported by Jiang et al. on 
the compressive properties of PCL/HA scaffolds produced with a similar 
manufacturing process [60]. Furthermore, as expected we observed a 
correlation between architecture, porosity and compressive modulus 
(Fig. 6D). Regardless of the formulation tested, NSNG and SNG archi-
tectures are stiffer in comparison to the more porous SG architecture 
(mean porosity ~ 50%), indicating how the laydown pattern influences 
the porosity values of the scaffold, which in turn result to affect its 
mechanical behaviour. From Fig. 2 it can be seen that the SG architec-
ture is achieved through reducing the amount of material in the upper 
layers. This enhances clearly makes the scaffold overall more porous, 
and means that these layers are more compliant when compressed. 
However, no significant differences were recorded between the NSNG 
and SNG architecture. Moreover, it was possible to conclude that the 
mechanical behaviour in compression is broadly unaffected by the 
formulation, and to some extent it can be tuned through the adjustment 
Fig. 4. FTIR spectra of A) PCL, HA and composite HA-based powders and B) PCL, SrHA and composite SrHA-based powders.  
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of the laydown pattern within the scaffold. Furthermore, the inclusion 
up to 20 wt% of HA or SrHA calcined powder in the polymeric matrix led 
to small and not statistically significant differences in the values of 
Young’s moduli in comparison to bare PCL scaffolds. In accordance to 
Myoung Hwan Kim et al. [46] and G�omez-Liz�arraga et al. [62], this 
behaviour may be recognised as a consequence of the mixing process of 
the two composite phases, which was performed through physical rather 
than chemical blending. Therefore, in light of these results, and based on 
the findings reported by Yilgor et al. according to which a shifted not 
graded design can lead to a better in vitro response [47], the PCL/20HA 
and PCL/20SrHA formulations printed with a SNG architecture were 
selected for further analysis, whereas bare PCL was used as control. 
3.3. Biological in vitro scaffold performance 
3.3.1. Cells viability, immunostaining and proliferation 
In order to evaluate the cytocompatibility of the 3D printed scaffolds, 
cells were seeded on the top of the scaffolds and cultured. All the scaf-
folds showed a favourable support for cells attachment, growth and 
proliferation. Live/Dead staining showed round-shaped live cells 
(green) attached to the scaffold in all the three samples at 24 h while the 
presence of HA phase in the PCL/20HA and PCL/20SrHA samples 
demonstrated to promote cells spreading, communication and agglom-
eration compared to the PCL scaffolds (Fig. 7a). In all the cases few dead 
cells (red) were observed. This was further confirmed by immuno-
staining (nuclei stained with DAPI and the cytoskeleton with 
rhodamine-phalloidin) that confirmed the scaffolds compatibility and 
the tendency of the hTERT MSCs to form agglomerates mainly in the 
samples where was present the HA phase compared with the bare PCL 
samples, characterised by a more homogenous distribution of the cells 
within all the scaffold (Fig. 7a). 
The proliferation of hTERT MSCs was qualitatively detected by MTT 
assay (Fig. 7b). In fact, as shown in Fig. 7b it was registered a positive 
trend on cell proliferation at day 3 and day 7 with a highly significant 
increase in the number of cells for all samples at day 21 compared with 
all the previous time points (p < 0.0001) (Fig. 7b) without significant 
differences among the three groups, meaning that the all the 3D printed 
structures allowed cellular proliferation. 
3.3.2. Osteogenic potential and mineralisation 
ALP is an early marker of osteogenic differentiation and higher ALP 
activity reveals strong cell-cell and cell-matrix interactions [30]. From 
the graph in Fig. 8a, at day 0 the ALP value is significantly higher in the 
samples without Sr (p < 0.0001), while at 14 days of culture Sr con-
taining scaffolds show a delay in the osteogenesis as confirmed by the 
Alizarin red assay (Fig. 7b) with a lower formation of calcium deposits 
compared with HA containing scaffolds [2]. Furthermore, an obvious 
decrease in the ALP activity was observed after 21 days of culture in all 
samples and this is related to cells mineralisation [63] as demonstrated 
by the visual presence of minerals stained with Alizarin Red (Fig. 8b). In 
Fig. 5. Representative microCT images of all the 3D printed scaffolds and cross section of the three different architectures produced (1 ¼ NSNG, 2 ¼ SNG and 3 ¼ SG 
architecture); [scale bar ¼ 2 mm]. 
Table 4 
Theoretical and experimental total porosity values of 3D printed scaffolds.  
Code Total porosity (%) 
Theoretical Experimental 
PCL – NSNG 41.56 36.6 � 1.4 
PCL – SNG 36.6 � 1.5 
PCL – SG 52.43 50.4 � 0.8 
PCL/10HA – NSNG 41.56 40.1 � 1.5 
PCL/10HA – SNG 42.2 � 1.1 
PCL/10HA – SG 52.43 54.4 � 1.8 
PCL/10SrHA – NSNG 41.56 42.3 � 1.8 
PCL/10 SrHA – SNG 43.0 � 2.5 
PCL/10SrHA – SG 52.43 52.9 � 1.6 
PCL/20HA – NSNG 41.56 42.4 � 0.7 
PCL/20HA – SNG 39.4 � 1.5 
PCL/20HA – SG 52.43 48.7 � 1.6 
PCL/20SrHA – NSNG 41.56 37.7 � 1.5 
PCL/20SrHA – SNG 36.6 � 1.1 
PCL/20SrHA – SG 52.43 47.5 � 1.2  
D. Pierantozzi et al.                                                                                                                                                                                                                            
Composites Science and Technology 191 (2020) 108069
8
fact, all the samples showed a more relevant presence of calcium de-
posits at 21 days compared with the previous time points (except for few 
deposits visible on the PCL/20HA samples after 14 days). Particularly, 
after 21 days of culture the presence of Sr seemed to enhance the min-
eralisation phenomenon, as demonstrated by the highest presence of red 
stained-deposits in this samples compared to the other samples (Fig. 8b). 
4. Conclusions 
In this study 3D printed composite scaffolds based on PCL, PCL/HA 
and PCL/SrHA were fabricated by advantageous extrusion-based 3D 
printing technology. MicroCT analysis revealed a reliable approach in 
providing information on the total porosity values (which resulted in the 
range of human cancellous bone) of the different architectures pro-
duced, also showing that all the printed scaffolds displayed a high level 
of fidelity to the original CAD model. In terms of biomechanical per-
formance, the presence of the ceramic phase (up to 20 wt%) in the 
polymeric matrix led to not statistically significant differences in the 
values of Young’s moduli in comparison to bare PCL scaffolds. Thus, it 
can be stated that the material formulation broadly unaffected the me-
chanical properties of the manufactured 3D scaffolds, which to some 
extent can be tailored through the adjustment of the scaffold architec-
ture. Moreover, concerning the biological performance, both polymeric 
and composite 3D printed scaffolds showed good levels of biocompati-
bility and a favourable support for cells’ attachment, growth and pro-
liferation. However, the SrHA containing scaffolds exhibited higher 
levels of mineralisation with respect to bare PCL and PCL/HA scaffolds 
following in vitro assays, hence indicating their promise for bone tissue 
engineering applications. 
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